Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Randomized Controlled Study of Modified Directly Observed HAART in Mozambique

NCT00272220 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00272220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00272220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Randomized Controlled Study of Modified Directly Observed HAART in Mozambique
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2004
Completion date
June 30, 2006
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immunodeficiency syndrome